Protocol Ledger

NCT07702292 · Phase II · RECRUITING

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Interventional Phase II clinical trial protocol NCT07702292 sponsored by Blue Earth Diagnostics in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-06-30 Enrollment: 71 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07702292
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)71 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07702292
Protocol FieldVerified Registry Value
NCT IdentifierNCT07702292
Consolidated Lead SponsorBlue Earth Diagnostics
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment71 participants (ESTIMATED)
Registered Start Date2026-06-30
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07702292
Hospital Research SiteLocationSite Profile
IRCCS Ospedale San RaffaeleMilan, ItalyOpen Hospital Dossier ->
University Medical Center GroningenGroningen, NetherlandsOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI